RE: A tweet from Suzy31 Jan 2023 12:05
This completes the first stage of the establishment of ValiRx’s internal translational Contract Research Organisation......Good to hear the firsrt stage of your new venture is complete.....
Looking forward to updates, preferably positive ones for Val BC201, CLX001, val301, val401
Also cash drain, monthly revenue from third party, remaining patent life.
All in all pleanty of newsd to come and hope Valarix are not shy in presenting their progress given...
ValiRx ACCELERATES the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the RAPID translation of innovative science into clinical development.
With our extensive and PROVEN experience in research and drug development, we select and incubate promising novel drug candidates and guide them through an optimised process of development, from pre-clinical studies to clinic and INVESTOR READY assets.
Frankly the above looks to me as it could be misconstrued as smoke and mirrors until we get genuine updates on core treatment lines.....methinks also this will be confirmed by investors via the next RNS, expected later this week.
Hopefully the pitiful current SP will recover, ney rise.
Please excuse poor gramme as cannot be ****d to check.....